NCT05421897View on ClinicalTrials.gov

Rapid Administration Pilot for Infusing Dinutuximab

PHASE1RecruitingINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Neuroblastoma

Interventions

DRUG

Dinutuximab with Chemotherapy

Rapid infusion of dinutuximab in 4 hours or less

Trial Locations (1)

90027

RECRUITING

Childrens Hospital Los Angeles, Los Angeles

Sponsors

Collaborators (1)

United Therapeutics

All Listed Sponsors

collaborator

United Therapeutics

INDUSTRY

lead

Children's Hospital Los Angeles

OTHER